Related references
Note: Only part of the references are listed.Mapping CSF biomarker profiles onto NIA-AA guidelines for Alzheimer's disease
Panagiotis Alexopoulos et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2016)
Cross-validation of biomarkers for the early differential diagnosis and prognosis of dementia in a clinical setting
Daniela Perani et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2016)
Transition rates between amyloid and neurodegeneration biomarker states and to dementia: a population-based, longitudinal cohort study
Clifford R. Jack et al.
LANCET NEUROLOGY (2016)
Prediction of AD dementia by biomarkers following the NIA-AA and IWG diagnostic criteria in MCI patients from three European memory clinics
Annapaola Prestia et al.
ALZHEIMERS & DEMENTIA (2015)
Diagnostic impact of CSF biomarkers for Alzheimer's disease in a tertiary memory clinic
Flora H. Duits et al.
ALZHEIMERS & DEMENTIA (2015)
Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage
Stephanie J. B. Vos et al.
BRAIN (2015)
Predicting Alzheimer's disease development: a comparison of cognitive criteria and associated neuroimaging biomarkers
Brandy L. Callahan et al.
ALZHEIMERS RESEARCH & THERAPY (2015)
Cerebrospinal fluid amyloid-β 42/40 ratio in clinical setting of memory centers: a multicentric study
Julien Dumurgier et al.
ALZHEIMERS RESEARCH & THERAPY (2015)
Impact of harmonization of collection tubes on Alzheimer's disease diagnosis
Sylvain Lehmann et al.
ALZHEIMERS & DEMENTIA (2014)
Limited agreement between biomarkers of neuronal injury at different stages of Alzheimer's disease
Panagiotis Alexopoulos et al.
ALZHEIMERS & DEMENTIA (2014)
The cerebrospinal fluid Alzheimer profile: Easily said, but what does it mean?
Flora H. Duits et al.
ALZHEIMERS & DEMENTIA (2014)
A data-driven model of biomarker changes in sporadic Alzheimer's disease
Alexandra L. Young et al.
BRAIN (2014)
High Tau Levels in Cerebrospinal Fluid Predict Rapid Decline and Increased Dementia Mortality in Alzheimer's Disease
M. Degerman Gunnarsson et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2014)
Who Needs Cerebrospinal Biomarkers? A National Survey in Clinical Practice
Anne Cecile Troussiere et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
Impact of cerebro-spinal fluid biomarkers of Alzheimer's disease in clinical practice: a multicentric study
Francois Mouton-Liger et al.
JOURNAL OF NEUROLOGY (2014)
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
Bruno Dubois et al.
LANCET NEUROLOGY (2014)
Variability of CSF Alzheimer's Disease Biomarkers: Implications for Clinical Practice
Stephanie J. B. Vos et al.
PLOS ONE (2014)
Diagnostic accuracy of markers for prodromal Alzheimer's disease in independent clinical series
Annapaola Prestia et al.
ALZHEIMERS & DEMENTIA (2013)
Mild Cognitive Impairment Due to Alzheimer Disease in the Community
Ronald C. Petersen et al.
ANNALS OF NEUROLOGY (2013)
The National Institute on Aging-Alzheimer's Association research criteria for mild cognitive impairment due to Alzheimer's disease: predicting the outcome
Liang-Hao Guo et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2013)
Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
Clifford R. Jack et al.
LANCET NEUROLOGY (2013)
Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study
Victor L. Villemagne et al.
LANCET NEUROLOGY (2013)
Prediction of Alzheimer disease in subjects with amnestic and nonamnestic MCI
Stephanie J. B. Vos et al.
NEUROLOGY (2013)
Prediction of dementia in MCI patients based on core diagnostic markers for Alzheimer disease
Annapaola Prestia et al.
NEUROLOGY (2013)
Biomarker Modeling of Alzheimer's Disease
Clifford R. Jack et al.
NEURON (2013)
An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease
Clifford R. Jack et al.
ANNALS OF NEUROLOGY (2012)
Recommendations to standardize preanalytical confounding factors in Alzheimer's and Parkinson's disease cerebrospinal fluid biomarkers: an update
Marta del Campo et al.
BIOMARKERS IN MEDICINE (2012)
Stage-Dependent Agreement between Cerebrospinal Fluid Proteins and FDG-PET Findings in Alzheimer's Disease
Igor Yakushev et al.
CURRENT ALZHEIMER RESEARCH (2012)
Accuracy of the Clinical Diagnosis of Alzheimer Disease at National Institute on Aging Alzheimer Disease Centers, 2005-2010
Thomas G. Beach et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2012)
Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort
N. S. M. Schoonenboom et al.
NEUROLOGY (2012)
Injury markers predict time to dementia in subjects with MCI and amyloid pathology
Ineke A. van Rossum et al.
NEUROLOGY (2012)
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Guy M. McKhann et al.
ALZHEIMERS & DEMENTIA (2011)
The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Marilyn S. Albert et al.
ALZHEIMERS & DEMENTIA (2011)
Utility of Combinations of Biomarkers, Cognitive Markers, and Risk Factors to Predict Conversion From Mild Cognitive Impairment to Alzheimer Disease in Patients in the Alzheimer's Disease Neuroimaging Initiative
Jesus J. Gomar et al.
ARCHIVES OF GENERAL PSYCHIATRY (2011)
Changing Concepts of Alzheimer Disease
Guy M. McKhann
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Genome-wide association study of CSF biomarkers Aβ1-42, t-tau, and p-tau181p in the ADNI cohort
S. Kim et al.
NEUROLOGY (2011)
Predicting MCI outcome with clinically available MRI and CSF biomarkers
D. Heister et al.
NEUROLOGY (2011)
Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects
John Q. Trojanowski et al.
ALZHEIMERS & DEMENTIA (2010)
Alzheimer's Disease Neuroimaging Initiative biomarkers as quantitative phenotypes: Genetics core aims, progress, and plans
Andrew J. Saykin et al.
ALZHEIMERS & DEMENTIA (2010)
Diagnostic Impact of CSF Biomarkers in a Local Hospital Memory Clinic
Maartje I. Kester et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2010)
Cerebrospinal fluid total tau as a marker of Alzheimer's disease intensity
Kaisa Samgard et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2010)
Comparing predictors of conversion and decline in mild cognitive impairment
S. M. Landau et al.
NEUROLOGY (2010)
Cerebrospinal Fluid Biomarker Signature in Alzheimer's Disease Neuroimaging Initiative Subjects
Leslie M. Shaw et al.
ANNALS OF NEUROLOGY (2009)
Comparison of Patient Therapy Adherence of Two Structural Different Memory Clinics
M. Weih et al.
FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE (2009)
CSF Biomarkers and Incipient Alzheimer Disease in Patients With Mild Cognitive Impairment
Niklas Mattsson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
CSF biomarkers predict rate of cognitive decline in Alzheimer disease
M. I. Kester et al.
NEUROLOGY (2009)
Relationships between biomarkers in aging and dementia
W. J. Jagust et al.
NEUROLOGY (2009)
MRI and CSF biomarkers in normal, MCI, and AD subjects Predicting future clinical change
P. Vemuri et al.
NEUROLOGY (2009)
Mild cognitive impairment: Epidemiology and dementia risk in an elderly italian population
Giovanni Ravaglia et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2008)
Cerebrospinal fluid levels of tau phosphorylated at threonine 181 in patients with Alzheimer's disease and vascular dementia
Sabrina Ravaglia et al.
NEUROLOGICAL SCIENCES (2008)
Conversion of amnestic Mild Cognitive Impairment to Dementia of Alzheimer type is independent to memory deterioration
Luca Rozzini et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2007)
Conversion of mild cognitive impairment to dementia in elderly subjects: A preliminary study in a memory and cognitive disorder unit
F. Maioli et al.
ARCHIVES OF GERONTOLOGY AND GERIATRICS (2007)
Do all patients with mild cognitive impairment progress to dementia?
P Alexopoulos et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2006)
Progression to dementia in clinical subtypes of mild cognitive impairment
P. Alexopoulos et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2006)